Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Capital Expenditures of $47000.0 in Q4 2025, up 370.0% quarter-over-quarter from $10000.0 in Q3 2025, and up 2250.0% on a YoY basis from $2000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Capital Expenditures history runs 16 years deep, the most recent figure standing at $47000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 2250.0% year-over-year to $47000.0; the TTM figure through Dec 2025 stood at $210000.0 (up 1300.0% YoY), while the FY2025 annual figure was $80000.0, up 3900.0% from the prior year.
- Capital Expenditures was $47000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from $10000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $190000.0 in Q1 2023 to a low of -$18000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $32800.0 across 5 years, with a median of $24000.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 3000.0% in 2022, then tumbled 109.47% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $1000.0 in 2021, then soared by 3000.0% to $31000.0 in 2022, then sank by 96.77% to $1000.0 in 2023, then soared by 100.0% to $2000.0 in 2024, then soared by 2250.0% to $47000.0 in 2025.
- The last three Capital Expenditures figures came in at $47000.0 (Q4 2025), $10000.0 (Q3 2025), and $106000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |